Relapsed or Refractory Lymphoma Including ENKL

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Relapsed or Refractory Lymphoma Including ENKL trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT06966154

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Se…

This open-label, multicenter Ib/II phase clinical trial investigates the safety, tolerability, and preliminary efficacy of tislezumab (anti-PD-1 monoclonal anti…

China68 participantsStarted 2025-05-26

Treatment: tislezumab, golidocitinib

All recent trials (2 shown)

SuspendedPhase 1/2

NCT06761677

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refract…

This study is a multi-center, global, open-label, Phase 1b/2 clinical study, and it will be conducted at multiple study sites in several countries, including Ja…

China, Japan43 participantsStarted 2025-06-09

Treatment: Brincidofovir